Treatment Sequencing Strategies in HER2-Positive Breast Cancer
Автор: Breast Cancers Today
Загружено: 2025-07-07
Просмотров: 97
Dr. Kelly McCann, of the UCLA Health David Geffen School of Medicine, shares her expert insights on sequencing therapies for patients with HER2-positive metastatic breast cancer. She examines the current first-line standard of taxane, trastuzumab, and pertuzumab, and explores how DESTINY-Breast09 findings may bring trastuzumab deruxtecan into earlier lines of treatment. The discussion includes practical strategies for managing toxicities such as interstitial lung disease (ILD) and balancing treatment effectiveness with quality of life.
#cancer #cancerresearch #oncology #breastcancer
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: